Phreesia, Inc. (NYSE:PHR) CFO Balaji Gandhi Sells 28,759 Shares

Phreesia, Inc. (NYSE:PHR) CFO Balaji Gandhi sold 28,759 shares of the company’s stock in a transaction dated Thursday, February 13th. The stock was sold at an average price of $30.00, for a total value of $862,770.00. Following the sale, the chief financial officer now owns 116,174 shares of the company’s stock, valued at $3,485,220. This represents a 19.84 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Balaji Gandhi also recently made the following trade(s):

• On Monday, January 27th, Balaji Gandhi sold 4,813 shares of Phreesia stock. The stock was sold at an average price of $27.48, for a total value of $132,261.24.
• On Tuesday, January 21st, Balaji Gandhi sold 5,827 shares of Phreesia stock. The stock was sold at an average price of $27.31, for a total value of $159,135.37.
• On Wednesday, January 15th, Balaji Gandhi sold 836 shares of Phreesia stock. The stock was sold at an average price of $26.98, for a total value of $22,555.28.
• On Monday, January 6th, Balaji Gandhi sold 3,195 shares of Phreesia stock. The stock was sold at an average price of $26.61, for a total value of $85,018.95.

Phreesia Stock Up 0.5 %

Shares of Phreesia stock opened at $29.99 on Wednesday. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.04. The business’s 50 day simple moving average is $26.93 and its 200-day simple moving average is $23.68. The stock has a market capitalization of $1.74 billion, a price-to-earnings ratio of -20.40 and a beta of 0.96. Phreesia, Inc. has a twelve month low of $17.07 and a twelve month high of $30.53.

Phreesia (NYSE:PHR) last announced its quarterly earnings results on Monday, December 9th. The company reported ($0.25) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.04. The business had revenue of $106.80 million for the quarter, compared to analysts’ expectations of $106.33 million. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The business’s quarterly revenue was up 16.6% on a year-over-year basis. During the same period in the prior year, the firm earned ($0.58) EPS. Equities research analysts forecast that Phreesia, Inc. will post -1.1 earnings per share for the current year.

Analyst Upgrades and Downgrades

PHR has been the subject of several analyst reports. Truist Financial upped their target price on Phreesia from $31.00 to $34.00 and gave the stock a “buy” rating in a research report on Wednesday, December 11th. Robert W. Baird decreased their target price on Phreesia from $34.00 to $30.00 and set an “outperform” rating for the company in a research report on Wednesday, December 11th. Piper Sandler reissued an “overweight” rating and issued a $33.00 price target (up previously from $31.00) on shares of Phreesia in a report on Wednesday, January 29th. Royal Bank of Canada raised Phreesia from a “sector perform” rating to an “outperform” rating and increased their price target for the company from $24.00 to $32.00 in a report on Wednesday, January 8th. Finally, JMP Securities reissued a “market outperform” rating and issued a $30.00 price target on shares of Phreesia in a report on Tuesday, December 10th. Thirteen equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, Phreesia presently has an average rating of “Buy” and an average price target of $31.15.

Institutional Trading of Phreesia

Large investors have recently added to or reduced their stakes in the business. Versor Investments LP acquired a new stake in Phreesia in the 3rd quarter valued at approximately $694,000. Zacks Investment Management acquired a new stake in Phreesia in the 3rd quarter valued at approximately $631,000. State Street Corp increased its position in Phreesia by 7.1% in the 3rd quarter. State Street Corp now owns 1,327,586 shares of the company’s stock valued at $30,256,000 after acquiring an additional 88,517 shares during the period. Wesbanco Bank Inc. increased its position in Phreesia by 76.9% in the 4th quarter. Wesbanco Bank Inc. now owns 46,000 shares of the company’s stock valued at $1,157,000 after acquiring an additional 20,000 shares during the period. Finally, Barclays PLC boosted its stake in Phreesia by 83.6% during the 3rd quarter. Barclays PLC now owns 94,929 shares of the company’s stock valued at $2,163,000 after purchasing an additional 43,225 shares in the last quarter. 92.10% of the stock is currently owned by institutional investors and hedge funds.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.